148 related articles for article (PubMed ID: 2229140)
1. Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth.
Hackenberg R; Hofmann J; Wolff G; Hölzel F; Schulz KD
J Cancer Res Clin Oncol; 1990; 116(5):492-8. PubMed ID: 2229140
[TBL] [Abstract][Full Text] [Related]
2. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells.
Hackenberg R; Hofmann J; Hölzel F; Schulz KD
J Cancer Res Clin Oncol; 1988; 114(6):593-601. PubMed ID: 2974456
[TBL] [Abstract][Full Text] [Related]
3. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057
[TBL] [Abstract][Full Text] [Related]
4. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
Benz C; Hollander C; Miller B
Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
[TBL] [Abstract][Full Text] [Related]
5. Regulation of androgen receptor mRNA and protein level by steroid hormones in human mammary cancer cells.
Hackenberg R; Hawighorst T; Filmer A; Slater EP; Bock K; Beato M; Schulz KD
J Steroid Biochem Mol Biol; 1992 Dec; 43(7):599-607. PubMed ID: 1472451
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells.
Hackenberg R; Turgetto I; Filmer A; Schulz KD
J Steroid Biochem Mol Biol; 1993 Nov; 46(5):597-603. PubMed ID: 8240982
[TBL] [Abstract][Full Text] [Related]
7. Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17 beta-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture.
Luthy IA; Bégin D; Labrie F
Endocrinology; 1988 Sep; 123(3):1418-24. PubMed ID: 3402389
[TBL] [Abstract][Full Text] [Related]
8. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
[TBL] [Abstract][Full Text] [Related]
9. Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1991; 17(3):197-210. PubMed ID: 1645605
[TBL] [Abstract][Full Text] [Related]
10. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
11. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor.
Hackenberg R; Hawighorst T; Filmer A; Nia AH; Schulz KD
Breast Cancer Res Treat; 1993; 25(3):217-24. PubMed ID: 8369523
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells.
Bentel JM; Birrell SN; Pickering MA; Holds DJ; Horsfall DJ; Tilley WD
Mol Cell Endocrinol; 1999 Aug; 154(1-2):11-20. PubMed ID: 10509795
[TBL] [Abstract][Full Text] [Related]
13. Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7).
Stover EP; Krishnan AV; Feldman D
Endocrinology; 1987 Jun; 120(6):2597-603. PubMed ID: 3569146
[TBL] [Abstract][Full Text] [Related]
14. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Couture P; Thériault C; Simard J; Labrie F
Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
[TBL] [Abstract][Full Text] [Related]
16. Regulation of renal N-nitrosodimethylamine demethylase activity by androgens, progestin, glucocorticoid, and estrogen in BALB/c mice.
Ahir S; Mohla S
Cancer Res; 1989 Jul; 49(14):3737-41. PubMed ID: 2786744
[TBL] [Abstract][Full Text] [Related]
17. Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells.
Labrie F; Poulin R; Simard J; Zhao HF; Labrie C; Dauvois S; Dumont M; Hatton AC; Poirier D; Mérand Y
Ann N Y Acad Sci; 1990; 595():130-48. PubMed ID: 2142871
[TBL] [Abstract][Full Text] [Related]
18. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Schoonen WG; Joosten JW; Kloosterboer HJ
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):423-37. PubMed ID: 8541240
[TBL] [Abstract][Full Text] [Related]
19. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Res; 1976 Dec; 36(12):4610-8. PubMed ID: 1000506
[TBL] [Abstract][Full Text] [Related]
20. Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion.
Shapiro E; Lippman ME
J Steroid Biochem; 1985 Jan; 22(1):15-20. PubMed ID: 3871880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
